本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

334.13
-14.6000-4.19%
成交量:32.60万
成交额:1.10亿
市值:74.19亿
市盈率:-18.60
高:351.20
开:350.00
低:331.24
收:348.73
数据加载中...
2023/03/03

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

重要事件披露

8-K - Current report
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

重要事件披露

8-K - Current report
2022/12/23

重要事件披露

8-K - Current report
2022/12/19

重要事件披露

8-K - Current report
2022/11/03

重要事件披露

8-K - Current report
2022/11/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

重要事件披露

8-K - Current report
2022/06/17

重要事件披露

8-K - Current report
2022/05/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]